The Post-Stroke Checklist : longitudinal use in routine clinical practice during first year after stroke
(2024) In BMC Cardiovascular Disorders 24(1).- Abstract
Background: Few studies describe the use of the Post-Stroke Checklist (PSC) as a tool for longitudinal stroke follow-up in clinical practice. We mapped the prevalence of stroke-related health problems and targeted interventions at 3 and 12 months post-stroke by using the PSC. Methods: Patients with acute stroke discharged home in 2018–2019 at Skåne University Hospital, Sweden, were invited to participate in a comprehensive nurse-led follow-up based on a 14-item PSC 3 and 12 months post-stroke. We measured time consumption, screened for stroke-related health problems, compared the findings, and recorded targeted healthcare interventions. Problems at 12 months were grouped into new, persistent, or none compared to the 3-month evaluation.... (More)
Background: Few studies describe the use of the Post-Stroke Checklist (PSC) as a tool for longitudinal stroke follow-up in clinical practice. We mapped the prevalence of stroke-related health problems and targeted interventions at 3 and 12 months post-stroke by using the PSC. Methods: Patients with acute stroke discharged home in 2018–2019 at Skåne University Hospital, Sweden, were invited to participate in a comprehensive nurse-led follow-up based on a 14-item PSC 3 and 12 months post-stroke. We measured time consumption, screened for stroke-related health problems, compared the findings, and recorded targeted healthcare interventions. Problems at 12 months were grouped into new, persistent, or none compared to the 3-month evaluation. Results: Of 200 consecutively included patients, 146 (77%) completed both the 3- and 12-month follow-ups. At 12-month follow-up, 36% of patients reported no stroke-related health problems, 24% reported persistent problems, and 40% reported new problems since the 3-month evaluation. New problems at 12 months were most common within the domains: secondary prevention (23%) and life after stroke (10%). Stroke recurrence rate was 7.5%, 43% had high blood pressure, and few smokers had quit smoking. At 12 months, 53% received at least one new healthcare intervention, compared to 84% at 3 months. Conclusions: Stroke-related health problems decreased beyond 3 months but were still present in two-thirds of patients at 1 year. This emphasizes the relevance of continuous structured follow-up using the PCS. However, the follow-up alone was insufficient to adequately achieve treatment targets for secondary prevention, which require intensified focus. Trial registration: ClinicalTrials.gov
(Less)
- author
- Månsson, Kristina LU ; Söderholm, Martin LU ; Berhin, Ida LU ; Pessah-Rasmussen, Hélène LU and Ullberg, Teresa LU
- organization
- publishing date
- 2024-12
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Complications, Follow-up, Modifiable stroke risk factors, Outcome, Quality of care, Stroke, Stroke prevention, Stroke rehabilitation
- in
- BMC Cardiovascular Disorders
- volume
- 24
- issue
- 1
- article number
- 601
- publisher
- BioMed Central (BMC)
- external identifiers
-
- scopus:85208081762
- pmid:39468444
- ISSN
- 1471-2261
- DOI
- 10.1186/s12872-024-04239-6
- language
- English
- LU publication?
- yes
- id
- b24f04a6-2216-4c02-b770-c420914354de
- date added to LUP
- 2024-12-03 12:21:14
- date last changed
- 2025-07-16 19:40:19
@article{b24f04a6-2216-4c02-b770-c420914354de,
abstract = {{<p>Background: Few studies describe the use of the Post-Stroke Checklist (PSC) as a tool for longitudinal stroke follow-up in clinical practice. We mapped the prevalence of stroke-related health problems and targeted interventions at 3 and 12 months post-stroke by using the PSC. Methods: Patients with acute stroke discharged home in 2018–2019 at Skåne University Hospital, Sweden, were invited to participate in a comprehensive nurse-led follow-up based on a 14-item PSC 3 and 12 months post-stroke. We measured time consumption, screened for stroke-related health problems, compared the findings, and recorded targeted healthcare interventions. Problems at 12 months were grouped into new, persistent, or none compared to the 3-month evaluation. Results: Of 200 consecutively included patients, 146 (77%) completed both the 3- and 12-month follow-ups. At 12-month follow-up, 36% of patients reported no stroke-related health problems, 24% reported persistent problems, and 40% reported new problems since the 3-month evaluation. New problems at 12 months were most common within the domains: secondary prevention (23%) and life after stroke (10%). Stroke recurrence rate was 7.5%, 43% had high blood pressure, and few smokers had quit smoking. At 12 months, 53% received at least one new healthcare intervention, compared to 84% at 3 months. Conclusions: Stroke-related health problems decreased beyond 3 months but were still present in two-thirds of patients at 1 year. This emphasizes the relevance of continuous structured follow-up using the PCS. However, the follow-up alone was insufficient to adequately achieve treatment targets for secondary prevention, which require intensified focus. Trial registration: ClinicalTrials.gov</p>}},
author = {{Månsson, Kristina and Söderholm, Martin and Berhin, Ida and Pessah-Rasmussen, Hélène and Ullberg, Teresa}},
issn = {{1471-2261}},
keywords = {{Complications; Follow-up; Modifiable stroke risk factors; Outcome; Quality of care; Stroke; Stroke prevention; Stroke rehabilitation}},
language = {{eng}},
number = {{1}},
publisher = {{BioMed Central (BMC)}},
series = {{BMC Cardiovascular Disorders}},
title = {{The Post-Stroke Checklist : longitudinal use in routine clinical practice during first year after stroke}},
url = {{http://dx.doi.org/10.1186/s12872-024-04239-6}},
doi = {{10.1186/s12872-024-04239-6}},
volume = {{24}},
year = {{2024}},
}